Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not...
Pharma major Lupin Limited (Lupin) announced the launch of Ethacrynic ...
Abbott, the global healthcare company, recently launched a new inactiv...
AstraZeneca India has announced the launch of Qtern® (Dapagli...
As Indian pharma companies prepare to shift from supplying commodities...
Novartis has announced the launch of the Novartis Biome India, a digit...
Keeping in view the country’s over dependence on import of Activ...
K T Rama Rao, Minister for Information Technology, Industries &am...
Zydus Cadila, an innovation-driven, global pharmaceutical company, ann...
Patient Centricity and Integrated Quality Management is the theme...
Codagenix, Inc., a clinical-stage biotechnology company developing pro...
Novartis has recently sold its anti-diabetic drug vildagliptin (brande...
Sun Dermatology, a division of Sun Pharmaceutical Industries, Inc., US...
As part of its quest to provide access to life-saving medication and m...
PerkinElmer, Inc., a global leader committed to innovating for a ...
Lupin Limited has announced the approval for its Leflunomide Tablets U...
Sun Pharmaceutical Industries Ltd. has announced that one of its wholl...
Zydus Cadila, an innovation-driven, global pharmaceutical company, ann...
